The predictive value of several markers in the progression to acquired immunodeficiency syndrome

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 3, 1998, Pages 169-173

  Planella, Teresa ^a,b   Cortés, Mariano ^a   Martínez Brú, Cecília ^a   Barrio, Josep ^a   Sambeat, Ma Antònia ^a   González Sastre, Francesc ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Biochemical markers; HIV infection; Lymphocyte count; Survival analysis

Indexed keywords

ADENOSINE DEAMINASE; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; CD4 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEOPTERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG ABUSE; ENZYME BLOOD LEVEL; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOSINE DEAMINASE; ADULT; AGE FACTORS; AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NEOPTERIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; SPAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031924240     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.031     Document Type: Article

References (39)

1. 6/l. AIDS 1996; 10:F44.
2. Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr 1995; 10:S34-S40.
3. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
4. Mofenson LM, Korelitz J, Meyer III WA, Bethel J, Rich K, Pahwa S, et al. The relationship between serum human immunodeficiency virus type I (HIV-1) RNA level, CD4 lymphocyte %, and long-term mortality risk in HIV-1-infected children. J Infect Dis 1997; 175:1029-38.
5. Phillips AN, Lee CA, Elford J, Janossy G, Timms A, Bofill M, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337:389-92.
6. Lagakos SW. Surrogate markers in AIDS clinical trials: conceptuals basis, validation and uncertainties. Clin Infect Dis 1993; 16(Suppl 1):S22-S25.
7. Saah AJ, Muñoz A, Kuo V, Fox R, Kaslow RA, Phair JP, et al. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the multicenter AIDS cohort study. Am J Epidemiol 1992; 135:1147-55.
8. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency syndrome virus type 1. N Engl J Med 1990; 322:166-72.
9. Centers for Disease Control. Equivalences for CD4+ T-lymphocyte count and percentages of total lymphocytes. Morb Mort Wkly Rep 1992; 41:1-14.
10. Thiele B, Schwartländer B, Pauli G. Assessment of lymphocyte phenotyping-result of the first ring test in Berlin. Lab Med 1990; 14:168-72.
11. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3:144-51.
12. Gorter RW, Vranizan KM, Osmond DH, Moss AR. Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS 1992; 6:1341-7.
13. Bélec L, Ripoll L, Matta F, Mbopi Keou FX, Cotigny S, Longuet NF, et al. Marqueurs biologiques prévisionnels d'evolution au cours de l'infection par le virus de l'immunodéficience humaine. Ann Biol Clin 1992; 50:621-37.
14. Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency virus-releated disease. Clin Microbiol Rev 1994; 1:14-28.
15. Goudsmit J, Paul DA. Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin. Epidemiol Infect 1987; 99:701-10.
16. DeWolf F, Lange JM, Houweling JT, Mulder JW, Beemster J, Schellekens PT, et al. Appearance of predictors of disease progression in relation to the development of AIDS. AIDS 1989; 3:563-9.
17. Eyster ME, Ballard JO, Gail MH, Drummond JE, Goedert JJ. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count. Ann Intern Med 1989; 110:963-9.
18. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, et al. A prospective study of human immunodeficiency virus type 1 infection and development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321:1141-8.
19. Moss AR, Bacchetti P, Osmond D, Krampf W, Chaisson RE, Stites D, et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three-year follow-up of the San Francisco General Hospital Cohort. Br Med J 1988; 296:745-50.
20. 2-Microglobulin as a prognostic marker for development of AIDS. Clin Chem 1985; 31:1411-2.
21. 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 1990; 4:207-14.
22. 2-microglobulin in HIV infection. Lancet 1992; 340:371-2.
23. Melmed RN, Taylor JM, Detels R, Bozorgmehri M, Fahey JL. Serum neopterin in HIV-infected subjects: indicator of significant pathology, CD4 T-cell changes, and the development of AIDS. J Acquir Immune Defic Syndr 1989; 2:70-6.
24. Krämer A, Viktor SZ, Fuchs D, Milstien S, Gail M, Yellin FJ, et al. Neopterin: a predictive marker of acquired immunodeficiency syndrome in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1989; 2:291-6.
25. Harrison NA, Skidmore SJ, Neopterin and beta-2-microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers. J Med Virol 1990; 32:128-33.
26. Lange JMA, DeWolf, Goudsmit J. Markers for progression in HIV infection. AIDS 1989; 3 (SD: S153-S60.
27. Sönnerborg AB, Von Stedingk LV, Hansson LO, Strannegard OO. Elevated neopterin and beta-2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS 1989; 3:277-83.
28. Lambin P, Lefrère JJ, Doiniel C, Fine JM, Salmon D, Salmon C. Neopterin and beta-2-microglobulin in serum of HIV-seropositive subjects during a two year follow up. Clin Chem 1988; 34:1367-8.
29. Schechter MT, Craib KJ, Le TN, Willoughby B, Douglas B, Sestak P, et al. Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts in homosexual men. AIDS 1989; 3:347-53.
30. Coates RA, Farewell VT, Raboud J, Read SE, Klein M, Mac-Fadden DK, et al. Using serial observations to identify predictors of progression to AIDS in the Toronto Sexual Contact Study. J Clin Epidemiol 1992; 42:245-53.
31. Fling JA, Fischer JR, Boswell NR, Reid MJ. The relationship of serum IgA concentration to human immunodeficiency virus infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United-States Air Force. J Allergy Clin Immnunol 1988; 82:965-70.
32. Martínez-Hernández D, Arenas-Barbero J, Navarro-Gallar F, García-Esteban R, Santos-Sancho J, Gomes-de-Terreros F. Adenosine deaminase in the acquired immunodeficiency syndrome. Clin Chem 1988; 34:1949.
33. Delia S, Mastroianni CM, Masseti AP, Turbessi G, Cirelli A, Catania S, et al. Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS). Clin Chem 1987; 33:1675.
34. Renouf JA, Wood A, Frazer H, Thong YH, Chalmers AH. Depressed activities of purines enzymes in lymphocytes of patients infected with human immunodeficiency virus. Clin Chem 1989; 35:1478-81.
35. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance of definition for AIDS among adolescents and adults. Morb Mort Wkly Rep 1992; 41 (No RR-17).
36. SIDA a Barcelona. Situació a 31 de març de 1996. (no 31). Vigilància epidemiològica. Institut Municipal de la Salut. Servei d'Epidemiologia. Ajuntament de Barcelona. Àrea de Salut Pública.
37. Centre d'estudies epidemiològies sobre la SIDA de Catalunya. Departement de Sanitat i Seguretat Social. Generalitat de Catalunya. 11 de juliol de 1996.
38. Casos de SIDA declarados en España según criterios de definición de caso para vigilancia epidemiológica CDC 1987/OMS 1988 o de la definición europea de 1993. Actualización a 31.3.94. Registro Nacional de casos de SIDA. Información epidemiológica. Pub of Seisida, vol 5 num 7, Julio-Agosto 1994:434-448. Centro Nacional de Epidemiología (CNE). Instituto de Salud "Carlos III" (ISC-III). Madrid. Informe trimestral 1/94.
39. La SIDA a Espanya. Registre Nacional de la SIDA. Pla Nacional sobre la SIDA. Estrella Tardor 1996;11 (3):31. Caixa d'Estalvis i Pensions de Barcelona, Eds.